KR102633795B1 - An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light - Google Patents
An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light Download PDFInfo
- Publication number
- KR102633795B1 KR102633795B1 KR1020230078966A KR20230078966A KR102633795B1 KR 102633795 B1 KR102633795 B1 KR 102633795B1 KR 1020230078966 A KR1020230078966 A KR 1020230078966A KR 20230078966 A KR20230078966 A KR 20230078966A KR 102633795 B1 KR102633795 B1 KR 102633795B1
- Authority
- KR
- South Korea
- Prior art keywords
- inorganic
- organic
- composition
- acid
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 150000002894 organic compounds Chemical class 0.000 claims abstract description 25
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000000903 blocking effect Effects 0.000 claims abstract description 20
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000004927 fusion Effects 0.000 claims abstract description 14
- 239000002131 composite material Substances 0.000 claims abstract description 13
- 229910052809 inorganic oxide Inorganic materials 0.000 claims abstract description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011787 zinc oxide Substances 0.000 claims abstract description 10
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 9
- 239000002537 cosmetic Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- -1 stick Substances 0.000 claims description 8
- 229930005346 hydroxycinnamic acid Natural products 0.000 claims description 5
- 235000010359 hydroxycinnamic acids Nutrition 0.000 claims description 5
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 claims description 5
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000000865 liniment Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000003595 mist Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000006087 Silane Coupling Agent Substances 0.000 claims description 3
- 241000021559 Dicerandra Species 0.000 claims 1
- 229910010272 inorganic material Inorganic materials 0.000 description 31
- 150000002484 inorganic compounds Chemical class 0.000 description 21
- 230000000475 sunscreen effect Effects 0.000 description 19
- 239000000516 sunscreening agent Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 150000007965 phenolic acids Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- LBQZVWQOPFFQJI-GGWOSOGESA-N (e)-3-[3-[5-[(e)-2-carboxyethenyl]-2-hydroxy-3-methoxyphenyl]-4-hydroxy-5-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(C=2C(=C(OC)C=C(\C=C\C(O)=O)C=2)O)=C1O LBQZVWQOPFFQJI-GGWOSOGESA-N 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 235000013985 cinnamic acid Nutrition 0.000 description 4
- 229930016911 cinnamic acid Natural products 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 244000062730 Melissa officinalis Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000006750 UV protection Effects 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 235000009048 phenolic acids Nutrition 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000006193 cichoric acid Nutrition 0.000 description 2
- 229930016920 cichoric acid Natural products 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- INYJZRKTYXTZHP-NNPIPJJVSA-N coutaric acid Chemical compound OC(=O)[C@H](O)[C@H](C(O)=O)OC(=O)\C=C\C1=CC=C(O)C=C1 INYJZRKTYXTZHP-NNPIPJJVSA-N 0.000 description 2
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XIWXUSFCUBAMFH-HWKANZROSA-N fertaric acid Chemical compound COC1=CC(\C=C\C(=O)OC(C(O)C(O)=O)C(O)=O)=CC=C1O XIWXUSFCUBAMFH-HWKANZROSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 150000007524 organic acids Chemical group 0.000 description 2
- INYJZRKTYXTZHP-UHFFFAOYSA-N p-Coumaroyl tartaric acid Natural products OC(=O)C(O)C(C(O)=O)OC(=O)C=CC1=CC=C(O)C=C1 INYJZRKTYXTZHP-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/622—Coated by organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물에 관한 것이다. 자외선 차단을 위한 조성물은 산화아연 및 이산화티탄으로부터 선택된 적어도 하나의 무기산화물; 및 무기산화물에 융합된 페놀 기(phenolic group)를 가지는 유기화합물을 포함한다.The present invention relates to a hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light. The composition for blocking ultraviolet rays includes at least one inorganic oxide selected from zinc oxide and titanium dioxide; and organic compounds having a phenolic group fused to an inorganic oxide.
Description
본 발명은 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물에 관한 것이고, 구체적으로 유기 화합물이 코팅된 무기 화합물에 의하여 자외선을 효과적으로 차단하는 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물에 관한 것이다.The present invention relates to a hybrid composite composition in the form of an organic-inorganic fusion for blocking harmful light, and specifically relates to a hybrid composite composition in the form of an organic-inorganic fusion for blocking harmful light that effectively blocks ultraviolet rays by an inorganic compound coated with an organic compound. .
자연광은 다양한 파장 대역을 포함하고, 가시광선 영역의 파장 대역, 320~400 nm 파장의 UV-A, 290~320 nm 파장의 UV-B 및 100~290 nm의 UV-C와 같은 광을 포함한다. 이와 같은 자외선 중 상대적으로 큰 파장을 가지는 UV-A 및 UV-B는 지표면에 도달하여 사람에게 영향을 미칠 수 있다. 예를 들어 이와 같은 자외선은 피부를 붉게 만들거나, 색소를 침착시키거나 또는 콜라겐을 손상시켜 주름이 생기게 할 수 있다. 또한 많은 양의 자외선에 노출되는 경우 자외선은 화상 또는 피부암을 유발할 수 있다. 그러므로 이와 같은 자외선에 피부가 노출되지 않도록 자외선이 차단될 필요가 있고, 자외선 차단을 위한 화장료 조성물에 대한 발명이 이 분야에 공지되어 있다. 특허공개번호 10-2012-0039205는 고형화제로 소듐 알킬기를 포함하는 수중유형 고형화 제형의 자외선 차단용 화장료 조성물에 대하여 개시한다. 또한 특허공개번호 10-2013-0066773은 에칠페률레이트를 유효성분으로 포함하는 자외선 화장료 조성물에 대하여 개시한다. 선행기술 또는 공지 기술은 유기계 화합물로 이루어지고, 이로 인하여 자외선 손상에 따른 피부 조직의 염증 또는 조직 손상 또는 피부 손상을 방지하는 기능을 가지지만 자외선이 피부에 도달하는 것을 차단하는 차단 기능이 약하다는 단점을 가진다. 또한 자외선 차단제의 사용에 따른 부작용이 발생할 가능성이 있다는 단점을 가진다. 그러므로 이와 같은 문제점을 해결할 수 있는 화장료 조성물이 만들어질 필요가 있다. Natural light includes various wavelength bands, including light in the visible region, UV-A with a wavelength of 320 to 400 nm, UV-B with a wavelength of 290 to 320 nm, and UV-C with a wavelength of 100 to 290 nm. . Among these ultraviolet rays, UV-A and UV-B, which have relatively large wavelengths, can reach the earth's surface and affect humans. For example, these ultraviolet rays can cause skin to turn red, become pigmented, or damage collagen, causing wrinkles to form. Additionally, if exposed to large amounts of UV rays, UV rays can cause burns or skin cancer. Therefore, it is necessary to block ultraviolet rays so that the skin is not exposed to such ultraviolet rays, and inventions regarding cosmetic compositions for blocking ultraviolet rays are known in the field. Patent Publication No. 10-2012-0039205 discloses a cosmetic composition for sunscreen in an oil-in-water solidified formulation containing a sodium alkyl group as a solidifying agent. Additionally, Patent Publication No. 10-2013-0066773 discloses an ultraviolet cosmetic composition containing ethyl feryl rate as an active ingredient. Prior art or known technology is made of organic compounds and has the function of preventing inflammation or tissue damage or skin damage caused by ultraviolet rays, but the disadvantage is that the blocking function to block ultraviolet rays from reaching the skin is weak. has It also has the disadvantage of possibly causing side effects due to the use of sunscreen. Therefore, there is a need to create a cosmetic composition that can solve these problems.
본 발명은 선행기술의 문제점을 해결하기 위한 것으로 아래와 같은 목적을 가진다.The present invention is intended to solve the problems of the prior art and has the following purposes.
본 발명의 목적은 페놀기를 가지는 유기화합물과 자외선 차단 기능을 가지는 무기 화합물이 융합된 하이브리드 형태에 의하여 안정성이 향상되면서 자외선이 효과적으로 차단되도록 하는 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물을 제공하는 것이다. The object of the present invention is to provide a hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light, which improves stability and effectively blocks ultraviolet rays by combining an organic compound with a phenol group and an inorganic compound with a UV-blocking function in a hybrid form. will be.
본 발명의 적절한 실시 형태에 따르면, 자외선 차단을 위한 조성물은 산화아연 및 이산화티탄으로부터 선택된 적어도 하나의 무기산화물; 및 무기산화물에 융합된 페놀 기(phenolic group)를 가지는 유기화합물을 포함한다. According to a preferred embodiment of the present invention, a composition for blocking ultraviolet rays includes at least one inorganic oxide selected from zinc oxide and titanium dioxide; and organic compounds having a phenolic group fused to an inorganic oxide.
본 발명의 다른 적절한 실시 형태에 따르면, 페놀 기는 페놀 산(phenolic acid) 및 아로마틱 아미노 산(aromatic amino acid)을 포함한다.According to another suitable embodiment of the invention, the phenol group includes phenolic acid and aromatic amino acid.
본 발명의 또 다른 적절한 실시 형태에 따르면, 무기산화물은 유기 화합물에 의하여 코팅이 된 분말 형태가 된다. According to another suitable embodiment of the present invention, the inorganic oxide is in the form of a powder coated with an organic compound.
본 발명의 또 다른 적절한 실시 형태에 따르면, 본 발명에 따른 조성물은 로션, 에멀션, 크림, 스틱, 밤, 스프레이 또는 미스트 형태의 화장료가 된다.According to another suitable embodiment of the present invention, the composition according to the present invention is a cosmetic in the form of lotion, emulsion, cream, stick, balm, spray or mist.
본 발명에 따른 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물은 유기 화합물과 무기물이 융합되어 안정성이 향상되면서 자외선 차단 효과가 높아지도록 한다. 본 발명에 따른 복합 조성물은 사용감이 우수하여 다양한 형태의 화장료로 사용될 수 있고, 부작용이 발생하지 않으면서 자외선 차단을 비롯하여 다양한 형태의 인체에 유리한 효과가 발생되도록 한다. 본 발명에 따른 복합 조성물은 로션, 에멀션, 크림, 스틱, 밤, 스프레이, 미스트 또는 이와 유사한 다양한 제형으로 만들어질 수 있고 이에 의하여 본 발명은 제한되지 않는다.The hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light according to the present invention combines organic compounds and inorganic materials to improve stability and increase ultraviolet ray blocking effect. The composite composition according to the present invention has an excellent feeling of use, so it can be used in various types of cosmetics, and produces various beneficial effects on the human body, including UV protection, without causing side effects. The composite composition according to the present invention can be made into various formulations such as lotion, emulsion, cream, stick, balm, spray, mist or similar, and the present invention is not limited thereby.
도 1은 본 발명에 따른 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물의 제조 과정의 실시 예를 도시한 것이다.
도 2는 본 발명에 따른 조성물에 의한 자외선 흡수능 시험 결과를 나타낸 것이다.
도 3은 본 발명에 따른 조성물의 자외선 차단 효과의 시험 결과를 나타낸 것이다.
도 4는 본 발명에 따른 조성물의 안전성 시험 결과를 도시한 것이다.
도 5는 본 발명에 따른 조성물이 피부에 도포되어 나타나는 백탁 현상의 결과를 도시한 것이다.Figure 1 shows an example of the manufacturing process of a hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light according to the present invention.
Figure 2 shows the results of an ultraviolet absorption ability test by the composition according to the present invention.
Figure 3 shows the test results of the ultraviolet ray blocking effect of the composition according to the present invention.
Figure 4 shows the safety test results of the composition according to the present invention.
Figure 5 shows the results of the white clouding phenomenon that appears when the composition according to the present invention is applied to the skin.
아래에서 본 발명은 첨부된 도면에 제시된 실시 예를 참조하여 상세하게 설명이 되지만 실시 예는 본 발명의 명확한 이해를 위한 것으로 본 발명은 이에 제한되지 않는다. 아래의 설명에서 서로 다른 도면에서 동일한 도면 부호를 가지는 구성요소는 유사한 기능을 가지므로 발명의 이해를 위하여 필요하지 않는다면 반복하여 설명이 되지 않으며 공지의 구성요소는 간략하게 설명이 되거나 생략이 되지만 본 발명의 실시 예에서 제외되는 것으로 이해되지 않아야 한다. Below, the present invention will be described in detail with reference to the embodiments shown in the attached drawings, but the examples are for a clear understanding of the present invention and the present invention is not limited thereto. In the description below, components having the same reference numerals in different drawings have similar functions, so unless necessary for understanding the invention, the description will not be repeated, and well-known components will be briefly described or omitted, but the present invention It should not be understood as being excluded from the embodiments.
본 발명에 따른 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물은 무기산화물; 및 무기 화합물에 융합된 페놀 기(phenolic acid)을 가지는 유기화합물을 포함한다. 무기산화물은 예를 들어 산화아연(zinc oxide) 또는 이산화티타늄(titanium oxide)을 포함할 수 있다. 또한 페놀 기를 갖는 유기화합물은 예를 들어 방향족 링(aromatic ring) 또는 유기 산(organic acid)과 같은 기능기를 갖는 방향족 산(aromatic acid)을 포함하고, 구체적으로 페놀 산(phenolic acid)과 방향족 아미노 산(aromatic amino acid)을 포함한다. 또한 페놀 산(phenolic acid)은 하이드록시신남 산(hydroxycinnamic acid), 카페익 산(caffeic acid), 치코르 산(cichoric acid), 신남 산(cinnamic acid), 클로로겐 산(chlorogenic acid), 다이페룰릭 산(diferulic acid), 쿠마르 산(coumaric acid), 페룰 산(ferulic acid), 시나핀 산(sinapinic acid), 카프타릭 산(caftraric acid), 코우타릭 산(coutaric acid) 및 페르타릭 산(fertaric acid)로 구성된 그룹으로부터 선택된 적어도 하나의 성분 또는 이들의 유도체를 포함한다. 또한 이들의 유도체는 예를 들어 신남 산의 하이드록시 유도체를 포함한다. 융합은 무기화합물과 유기화합물이 결합된 형태를 포함하고, 예를 들어 유기 화합물이 분말 형태의 무기산화물의 표면에 코팅이 되거나, 혼화(blending)이 되거나, 유기화합물의 기가 무기화합물에 결합된 형태가 되거나, 유기화합물이 용매에 용해가 되면서 무기화합물을 둘러싸는 형태가 될 수 있다. 이와 같은 융합에 의하여 분말 형태의 무기화합물이 서로 물리적 또는 화학적으로 서로 분리될 수 있고 이에 의하여 조성물 전체에 걸쳐 무기화합물이 균일하게 분포될 수 있다, 아래에서 이와 같은 조성물이 제조되는 과정에 대하여 설명된다.The hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light according to the present invention includes an inorganic oxide; and organic compounds having a phenol group (phenolic acid) fused to an inorganic compound. Inorganic oxides may include, for example, zinc oxide or titanium dioxide. Additionally, organic compounds having a phenol group include, for example, aromatic acids having functional groups such as aromatic rings or organic acids, specifically phenolic acids and aromatic amino acids. (aromatic amino acid) included. Additionally, phenolic acids include hydroxycinnamic acid, caffeic acid, cichoric acid, cinnamic acid, chlorogenic acid, and diperulic acid. diferulic acid, coumaric acid, ferulic acid, sinapinic acid, caftraric acid, coutaric acid and fertaric acid ) and at least one component selected from the group consisting of or derivatives thereof. Also their derivatives include, for example, the hydroxy derivatives of cinnamic acid. Fusion includes a form in which an inorganic compound and an organic compound are combined, for example, an organic compound is coated on the surface of an inorganic oxide in powder form, blended, or a group of an organic compound is bonded to an inorganic compound. Alternatively, the organic compound may dissolve in the solvent and surround the inorganic compound. Through such fusion, inorganic compounds in powder form can be physically or chemically separated from each other, and thereby the inorganic compounds can be uniformly distributed throughout the composition. The process of producing such a composition is explained below. .
도 1은 본 발명에 따른 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물의 제조 과정의 실시 예를 도시한 것이다. Figure 1 shows an example of the manufacturing process of a hybrid composite composition in the form of organic-inorganic fusion for blocking harmful light according to the present invention.
도 1을 참조하면, 하이브리드 복합 조성물의 제조 과정은 무기 화합물을 준비하는 단계(P11); 무기화합물을 분쇄 또는 밀링을 하여 입도를 조절하여 나노 입자로 만드는 단계(P12); 나노 무기화합물의 표면을 처리하는 단계(P14); 유기화합물을 준비하고(P14), 나노 무기화합물과 융합시키는 단계(P15); 및 융합 조정물의 pH를 조절하는 단계(P16)을 포함한다.Referring to Figure 1, the manufacturing process of the hybrid composite composition includes preparing an inorganic compound (P11); A step of crushing or milling the inorganic compound to adjust the particle size to make nanoparticles (P12); Processing the surface of the nano-inorganic compound (P14); Preparing an organic compound (P14) and fusing it with a nano-inorganic compound (P15); and adjusting the pH of the fusion agent (P16).
무기화합물은 예를 들어 산화아연, 이산화티타늄 또는 이들의 혼합물이 될 수 있고, 분말 형태로 준비될 수 있다(P11). 산화아연 또는 이산화티타늄은 가시광선 파장 대역의 광을 투과시키면 320 내지 400 ㎚ 파장을 가지는 UV-A 자외선 광 또는 280 내지 320 ㎚의 파장을 가지는 UV-B 자외선 광을 분산시켜 이와 같은 자외선이 피부에 도달하는 것을 차단하는 특성을 가질 필요가 있다. 이와 같은 가시광선의 투과 및 자외선의 차단 특성은 무기화합물의 입자 크기에 따라 크게 영향을 받으므로 무기화합물의 입도가 조절될 필요가 있다. 무기화합물은 예를 들어 자외선 최대 파장의 1/4에 해당하는 100 ㎚의 직경을 가지는 나노 입자로 만들어질 수 있고, 나노 무기화합물의 평균 직경은 100 ㎚ 이하가 되면서 30 내지 50 ㎚의 직경을 가지는 나노 무기화합물이 80 % 이상이 되도록 입도가 조절될 수 있다(P12). 다양한 밀링 장치 또는 균질기에 의하여 무기화합물이 나노 무기화합물로 만들어질 수 있고, 이와 같이 만들어진 나노 무기화합물에 대하여 선택적으로 표면 처리가 될 수 있다(P13). 표면 처리는 나노 무기화합물의 분산성을 향상시키면서 페놀 기와 결합이 용이하도록 하는 기능을 가진다. 표면 처리는 예를 들어 실란 커플링제에 의하여 표면 개질이 되는 방식으로 진행될 수 있다. 예를 들어 표면 처리를 위한 나노 무기화합물이 메틸에틸케톤 용매에 투입되어 15 내지 25 ℃의 온도에서 1 내지 10 시간 동안 교반이 될 수 있고, 교반 과정에서 5 내지 60분 동안 초음파 처리가 될 수 있다. 이와 같은 방식으로 표면 처리가 된 나노 무기화합물이 건조가 되어 나노 무기화합물 분말로 만들어질 수 있다.The inorganic compound may be, for example, zinc oxide, titanium dioxide, or a mixture thereof, and may be prepared in powder form (P11). When zinc oxide or titanium dioxide transmits light in the visible wavelength range, it disperses UV-A ultraviolet light with a wavelength of 320 to 400 ㎚ or UV-B ultraviolet light with a wavelength of 280 to 320 ㎚, so that such ultraviolet rays do not penetrate the skin. It needs to have properties that block it from reaching it. Since the visible light transmission and ultraviolet ray blocking properties are greatly affected by the particle size of the inorganic compound, the particle size of the inorganic compound needs to be adjusted. For example, the inorganic compound can be made of nanoparticles with a diameter of 100 nm, which corresponds to 1/4 of the maximum wavelength of ultraviolet rays, and the average diameter of the nano-inorganic compound is 100 nm or less and has a diameter of 30 to 50 nm. The particle size can be adjusted so that the nano inorganic compound is more than 80% (P12). Inorganic compounds can be made into nano-inorganic compounds using various milling devices or homogenizers, and the nano-inorganic compounds thus made can be selectively surface treated (P13). Surface treatment has the function of improving the dispersibility of nano-inorganic compounds and facilitating their bonding with phenol groups. Surface treatment may be carried out by, for example, surface modification using a silane coupling agent. For example, nano inorganic compounds for surface treatment can be added to a methyl ethyl ketone solvent and stirred at a temperature of 15 to 25 ° C for 1 to 10 hours, and ultrasonicated for 5 to 60 minutes during the stirring process. . Nano-inorganic compounds surface-treated in this way can be dried and made into nano-inorganic compound powder.
페놀 기를 가지는 유기화합물이 준비될 수 있고(P14), 페놀 기를 갖는 유기화합물은 예를 들어 방향족 링(aromatic ring) 또는 유기 산(organic acid)과 같은 기능기를 갖는 방향족 산(aromatic acid)을 포함하고, 구체적으로 페놀 산(phenolic acid)과 방향족 아미노 산(aromatic amino acid)을 포함한다. 또한 페놀 산(phenolic acid)은 하이드록시남 산(hydroxycinnamic acid), 카페익 산(caffeic acid), 치코르 산(cichoric acid), 신남 산(cinnamic acid), 클로로겐 산(chlorogenic acid), 다이페룰릭 산(diferulic acid), 쿠마르 산(coumaric acid), 페룰 산(ferulic acid), 시나핀 산(sinapinic acid), 카프타릭 산(caftraric acid), 코우타릭 산(coutaric acid) 및 페르타릭 산(fertaric acid)로 구성된 그룹으로부터 선택된 적어도 하나의 성분 또는 이들의 유도체를 포함할 수 있다. 또한 이들의 유도체는 예를 들어 신남 산의 하이드록시 유도체를 포함할 수 있다. 그리고 이와 같은 유기화합물에 나노 무기화합물이 첨가되어 융합될 수 있다(P15). 융합되는 유기화합물과 무기화합물은 예를 들어 유기화합물 100 wt%에 대하여 무기화합물 1 내지 2,000 wt%가 투입될 수 있다. 유기화합물은 용액 형태로 준비될 수 있고, 예를 들어 에틸렌글리콜, 프로필렌글리콜, 알코올 용매 또는 이와 유사한 용매에 정해진 양의 페놀 산이 함유하는 화합물이 투입되는 방법으로 용매가 만들어질 수 있다. 이와 같은 용액에 분산성을 향상시키기 위하여 예를 들어 메타크릴산메틸(MMA), 오가노몰리고 실록산, 오가노폴리실록산 또는 실리콘계 계면활성제가 첨가될 수 있다. 이후 이와 같은 형성된 분산 용매에 나노 무기화합물 분말이 정해진 양으로 첨가되어 용액 형태의 조성물이 만들어질 수 있다(P15). 이와 같이 만들어진 조성물은 예를 들어 로션, 에멀션, 크림, 스틱, 밤, 스프레이 또는 미스트 형태로 만들어지는 화장품의 소재로 사용될 수 있다. 산화아연 또는 이산화티탄의 자외선 차단 효과는 pH에 따라 다르고, 예를 들어 조성물에 적절한 pH 조절제가 첨가되어 pH가 4.0 내지 7.5가 되도록 조절될 수 있다(P16). pH 조절은 다양한 단계에서 이루어질 수 있고 제시된 실시 예에 제한되지 않는다.An organic compound having a phenol group can be prepared (P14), and the organic compound having a phenol group includes, for example, an aromatic acid having a functional group such as an aromatic ring or an organic acid. , specifically includes phenolic acid and aromatic amino acid. Additionally, phenolic acids include hydroxycinnamic acid, caffeic acid, cichoric acid, cinnamic acid, chlorogenic acid, and diperulic acid. diferulic acid, coumaric acid, ferulic acid, sinapinic acid, caftraric acid, coutaric acid and fertaric acid ) may include at least one component selected from the group consisting of or derivatives thereof. Derivatives of these may also include, for example, hydroxy derivatives of cinnamic acid. And nano-inorganic compounds can be added to such organic compounds to fuse them (P15). As for the organic and inorganic compounds to be fused, for example, 1 to 2,000 wt% of the inorganic compound may be added to 100 wt% of the organic compound. Organic compounds can be prepared in solution form, for example, a solvent can be created by adding a predetermined amount of a compound containing phenolic acid into ethylene glycol, propylene glycol, alcohol solvent, or similar solvent. To improve dispersibility in such a solution, for example, methyl methacrylate (MMA), organomolygo siloxane, organopolysiloxane, or silicone-based surfactant may be added. Thereafter, a predetermined amount of nano-inorganic compound powder can be added to the formed dispersion solvent to create a composition in the form of a solution (P15). The composition prepared in this way can be used as a material for cosmetics made in the form of, for example, lotion, emulsion, cream, stick, balm, spray or mist. The UV blocking effect of zinc oxide or titanium dioxide varies depending on pH, and for example, the pH can be adjusted to 4.0 to 7.5 by adding an appropriate pH adjuster to the composition (P16). pH adjustment can be accomplished at various stages and is not limited to the presented examples.
아래에서 이와 같은 제조 과정에 따라 본 발명에 따른 조성물이 제조되는 실시 예에 대하여 설명된다.Below, an example in which the composition according to the present invention is manufactured according to this manufacturing process will be described.
실시 예Example
실시 예1Example 1
산화아연(ZnO)을 균질기에서 밀링을 하여 35 내지 40 ㎚의 평균 직경을 가지는 나노 입자 분말로 만들어 과일로부터 추출된 하이드록시신남 산과 함께 에틸렌글리콜에 첨가되어 융합이 되었다. 300 ㎖의 에틸렌글리콜에 3 wt%의 산화아연 및 1 wt%의 하이드록시신남 산이 투입되었고, 0.1 wt%의 오가노폴리실록산이 투입되어 20 ℃의 온도에서 150 rmp의 속도로 5 시간 동안 교반을 하고, pH가 6.5가 되도록 조절하면서 투명한 형태의 조성물을 제조하였다.Zinc oxide (ZnO) was milled in a homogenizer to make nanoparticle powder with an average diameter of 35 to 40 nm, which was added to ethylene glycol together with hydroxycinnamic acid extracted from fruit and fused. 3 wt% of zinc oxide and 1 wt% of hydroxycinnamic acid were added to 300 ml of ethylene glycol, and 0.1 wt% of organopolysiloxane was added and stirred for 5 hours at a temperature of 20°C and a speed of 150 rmp. , a transparent composition was prepared while adjusting the pH to 6.5.
실시 예2 Example 2
동일한 양의 이산화티탄이 사용된 것을 제외하고 실시 예1과 동일한 방법으로 조성물이 제조되었다.A composition was prepared in the same manner as Example 1 except that the same amount of titanium dioxide was used.
실시 예3Example 3
동일한 양의 산화아연과 이산화티탄이 사용된 것을 제외하고 실시 예1과 동일한 방법으로 조성물이 제조되었다.A composition was prepared in the same manner as Example 1, except that the same amounts of zinc oxide and titanium dioxide were used.
실시 예4 Example 4
실란 커플링제에 의하여 표면 개질이 된 산화아연이 사용된 것을 제외하고 실시 예1과 동일한 방법으로 조성물이 제조되었다.A composition was prepared in the same manner as Example 1, except that zinc oxide surface-modified by a silane coupling agent was used.
효능 시험efficacy test
실시 예1 내지 4에 따라 제조된 조성물에 대한 효능 시험이 이루어졌다. 효능 시험은 가시광선 투과율, 자외선 흡광도 측정, 자외선 차단 효과, 제형 안정성 평가 및 백탁 현상 개선 효과에 대하여 이루어졌다.Efficacy tests were conducted on the compositions prepared according to Examples 1 to 4. Efficacy tests were conducted on visible light transmittance, ultraviolet absorbance measurement, ultraviolet ray blocking effect, formulation stability evaluation, and white turbidity improvement effect.
실시 예1 내지 4에 따른 조성물의 550 ㎚ 파장 대역의 가시광선 투과율을 각각 아래와 같았다.The visible light transmittance of the compositions according to Examples 1 to 4 in the 550 nm wavelength band were as follows.
실시 예4에 따른 조성물이 가장 높은 가시광선 투과율을 나타냈고, 이는 실시 예4에 따른 조성물의 분산성이 우수한 것에 따른 것으로 보인다. 실시 예1 내지 3의 경우 가시광선의, 투과율이 모두 75 % 이상이 되는 것으로 나타났다.실시 예 1에 따른 조성물의 UV-A 및 UV-B 파장 대역의 자외선 흡수능이 UV-VIS 포토스펙트로포토미터(photospectrophometer)를 이용하여 측정되었고, 측정 결과가 도 2로 제시되었다. 도 2의 좌측은 공지의 유기 자외선 차단제의 자외선 흡광도를 측정한 결과를 도시한 것이고, 도 2의 우측의 실시 예1에 따른 조성물의 자외선 흡광도를 측정한 결과를 도시한 것이다. 본 발명에 따른 조성물은 UV-A 및 UV-B 전체 파장 영역에 대하여 흡광도가 우수하다는 것을 알 수 있다.The composition according to Example 4 showed the highest visible light transmittance, which appears to be due to the excellent dispersibility of the composition according to Example 4. In the case of Examples 1 to 3, the transmittance of visible light was found to be more than 75%. The ultraviolet ray absorption ability of the composition according to Example 1 in the UV-A and UV-B wavelength bands was measured using a UV-VIS photospectrophotometer. ), and the measurement results are presented in Figure 2. The left side of Figure 2 shows the results of measuring the ultraviolet absorbance of a known organic sunscreen, and the right side of Figure 2 shows the results of measuring the ultraviolet light absorbance of the composition according to Example 1. It can be seen that the composition according to the present invention has excellent absorbance in the entire UV-A and UV-B wavelength range.
자외선 차단 효과의 시험을 위한 UV-B 감수성 효모 시험(UV-B sensitive yeast bio assay)이 진행되었고, 결과가 도 3으로 제시되었다. 시험은 in vitro bio-assay 방식으로 시행되었고, 시험을 위하여 배지에 효모 균액을 도말한 후 페트리디시의 뚜껑에 구역을 나누어 기본 선크림 베이스에 유무기 단순혼합물 0.2 wt% 첨가한 시료와 실시 예2에 따른 유무기 융합복합분체 0.2 wt%를 일정량 도포하였다. 기본 선크림 base는 자외선 차단제를 포함하지 않고, 공지된 자외선 차단제 독립적으로 동일 양으로 도포되었고 각각의 영역에 UV-B 자외선을 120 내지 300초 동안 간 조사시키고 35 ℃ 인큐베이터에서 이틀 동안 배양하여 균이 성장 수준이 확인되었다. 도 3에 도시된 것처럼 공지의 자외선 차단제 및 실시 예2에 따른 조성물의 도포 영역에서 균의 성장이 확인되었고 선크림 베이스의 도포 영역에서 균이 성장하지 못하는 것이 확인되었다. 또한 실시 예에 따른 도포 영역의 균의 성장 밀도가 높다는 것이 확인되었다.A UV-B sensitive yeast bio assay was conducted to test the UV blocking effect, and the results are presented in Figure 3. The test was conducted using an in vitro bio-assay method. For the test, the yeast bacterial solution was smeared on the medium, then the lid of the Petri dish was divided into sections, and the sample in which 0.2 wt% of a simple organic-inorganic mixture was added to the basic sunscreen base was added to the sample in Example 2. A certain amount of 0.2 wt% of the organic-inorganic fusion composite powder was applied. The basic sunscreen base does not contain a sunscreen, and known sunscreens are applied independently in the same amount, and each area is irradiated with UV-B ultraviolet rays for 120 to 300 seconds and incubated in a 35°C incubator for two days to grow bacteria. The level has been confirmed. As shown in Figure 3, growth of bacteria was confirmed in the area where the known sunscreen and the composition according to Example 2 were applied, and it was confirmed that bacteria did not grow in the area where the sunscreen base was applied. In addition, it was confirmed that the growth density of bacteria in the application area according to the example was high.
자외선 차단을 위한 시험을 위한 SPF(Sun protection Factor)가 측정되었고, 측정을 위하여 샘플 홀더(Sample Holder)에 Transpore Tape 55.5 ㎠를 부착시킨 후 실시 예에 따른 조성물 2 mg/㎠를 취하여 Transpore Tape 위의 비접착면에 골고루 바르고. 도포가 된지 15분이 경과된 후 SPF-290 Analyzer를 이용하여 SPF 수치를 측정하였고 측정 결과가 표 2로 제시되었고, 비교 예는 공지의 자외선 차단제의 시험 결과를 나타낸 것이다.The SPF (Sun protection Factor) for testing for UV protection was measured, and for measurement, 55.5 cm2 of Transpore Tape was attached to the sample holder, and then 2 mg/cm2 of the composition according to the example was taken and placed on the Transpore Tape. Apply evenly to the non-adhesive surface. 15 minutes after application, the SPF value was measured using an SPF-290 Analyzer, and the measurement results are presented in Table 2. Comparative examples show the test results of known sunscreens.
조성물의 안정성이 시험되었고, 안정성 시험을 위하여 침전 여부 및 갈변 현상이 시험되었고, 시험 결과가 도 4로 제시되었다. 실시 예1에 따른 조성물 1 wt% 및 공지의 자외선 차단제 1 wt%가 알코올 용매에 첨가되어 25 ℃의 온도에서 48 시간 동안 방치되었고, 도 4의 좌측 및 우측은 각각 실시 1에 따른 조성물 및 공지의 자외선 차단제의 시험 결과를 나타낸 것이다. 도 4로부터 알 수 있는 것처럼, 본 발명에 따른 조성물의 경우 바닥 침전이 발생되지 않고, 갈변 현상이 나타나지 않는 것으로 확인되었다. 자외선 차단제는 피부의 안전을 목적으로 사용하는 기능성 화장료에 해당하지만 미용적인 측면도 고려될 필요가 있다. 공지의 무기계 자외선 차단제의 경우 피부에 바르는 경우 무기계 자외선 차단 소재 성분으로 인하여 도포 부위가 하얗게 되는 백탁 현상 및 끈적거림이 발생할 수 있다. 실시 예1에 따른 조성물 및 공지의 무기계 자외선 차단제가 피부에 도포되었고, 25℃의 온도의 야외 자외선에 노출된 시험 결과가 도 5로 제시되었다. 좌측 부위는 본 발명에 따른 조성물이 도포된 부위에 해당하고 우측 부위는 공지의 무기계 자외선 차단제가 도포된 부위에 해당한다. 도 5로부터 알 수 있는 것처럼 본 발명에 따른 조성물의 경우 백탁 현상 및 끈적거림이 현저하게 감소한다는 것을 알 수 있다.위에서 본 발명은 제시된 실시 예를 참조하여 상세하게 설명이 되었지만 이 분야에서 통상의 지식을 가진 자는 제시된 실시 예를 참조하여 본 발명의 기술적 사상을 벗어나지 않는 범위에서 다양한 변형 및 수정 발명을 만들 수 있을 것이다. 본 발명은 이와 같은 변형 및 수정 발명에 의하여 제한되지 않으며 다만 아래에 첨부된 청구범위에 의하여 제한된다.The stability of the composition was tested, and precipitation and browning were tested for stability testing, and the test results are presented in Figure 4. 1 wt% of the composition according to Example 1 and 1 wt% of a known sunscreen were added to an alcohol solvent and left at a temperature of 25 ° C. for 48 hours. The left and right sides of Figure 4 are the composition according to Example 1 and the known sunscreen, respectively. This shows the test results of sunscreen. As can be seen from Figure 4, it was confirmed that in the case of the composition according to the present invention, no sedimentation occurred at the bottom and no browning phenomenon occurred. Sunscreens are functional cosmetics used for skin safety, but cosmetic aspects also need to be considered. In the case of known inorganic sunscreens, when applied to the skin, white clouding and stickiness may occur in the application area due to the inorganic sunscreen material components. The composition according to Example 1 and a known inorganic sunscreen were applied to the skin, and the test results of exposure to outdoor ultraviolet rays at a temperature of 25°C are shown in FIG. 5. The left area corresponds to the area where the composition according to the present invention was applied, and the right area corresponds to the area where a known inorganic sunscreen was applied. As can be seen from Figure 5, it can be seen that the white cloud phenomenon and stickiness are significantly reduced in the case of the composition according to the present invention. Although the present invention has been described in detail above with reference to the presented examples, it is known in the art Those who have this will be able to make various variations and modifications without departing from the technical spirit of the present invention by referring to the presented embodiments. The present invention is not limited by such variations and modifications, but is limited by the claims appended below.
P11: 무기화합물 준비 P12: 분쇄/입도 조절
P13: 표면 처리 P14: 유기화합물
P15: 융합 P16: pH 조절P11: Preparation of inorganic compounds P12: Grinding/Particle size control
P13: Surface treatment P14: Organic compounds
P15: Fusion P16: pH control
Claims (2)
산화아연 및 이산화티탄으로부터 선택된 적어도 하나의 무기산화물; 및
무기산화물에 융합된 페놀 기(phenolic group)를 가지는 유기화합물을 포함하고,
페놀 기는 하이드록시신남 산(hydroxycinnamic acid)을 포함하고,
무기산화물은 실란 커플링제에 의하여 표면 개질이 된 후 유기 화합물에 의하여 코팅이 된 분말 형태가 되는 것을 특징으로 하는 유해 광 차단용 유무기 융합 형태의 하이브리드 복합 조성물.In a composition for blocking ultraviolet rays,
At least one inorganic oxide selected from zinc oxide and titanium dioxide; and
Contains organic compounds having a phenolic group fused to an inorganic oxide,
Phenol groups include hydroxycinnamic acid,
A hybrid composite composition in the form of an organic-inorganic fusion for blocking harmful light, characterized in that the inorganic oxide is surface modified by a silane coupling agent and then coated with an organic compound in the form of a powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230078966A KR102633795B1 (en) | 2021-01-22 | 2023-06-20 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210009033A KR20220106285A (en) | 2021-01-22 | 2021-01-22 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
KR1020230078966A KR102633795B1 (en) | 2021-01-22 | 2023-06-20 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210009033A Division KR20220106285A (en) | 2021-01-22 | 2021-01-22 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230096938A KR20230096938A (en) | 2023-06-30 |
KR102633795B1 true KR102633795B1 (en) | 2024-02-02 |
Family
ID=82606430
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210009033A KR20220106285A (en) | 2021-01-22 | 2021-01-22 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
KR1020230078966A KR102633795B1 (en) | 2021-01-22 | 2023-06-20 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210009033A KR20220106285A (en) | 2021-01-22 | 2021-01-22 | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR20220106285A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020050561A (en) * | 2018-09-28 | 2020-04-02 | 住友大阪セメント株式会社 | Surface-treated metal oxide particle, dispersion, cosmetic and method for manufacturing surface-treated metal oxide particle |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101756697B1 (en) | 2010-10-15 | 2017-07-13 | (주)아모레퍼시픽 | Solid cosmetic composition of oil in water for blocking ultraviolet rays |
KR20130066773A (en) | 2011-12-13 | 2013-06-21 | 한국콜마주식회사 | Cosmetic composition for blocking ultraviolet-a comprising ehtyl ferulate |
KR101922489B1 (en) * | 2017-03-30 | 2018-11-27 | 한국과학기술원 | ROS-inhibiting, UV-screening composite particles and the use thereof |
-
2021
- 2021-01-22 KR KR1020210009033A patent/KR20220106285A/en active Application Filing
-
2023
- 2023-06-20 KR KR1020230078966A patent/KR102633795B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020050561A (en) * | 2018-09-28 | 2020-04-02 | 住友大阪セメント株式会社 | Surface-treated metal oxide particle, dispersion, cosmetic and method for manufacturing surface-treated metal oxide particle |
Also Published As
Publication number | Publication date |
---|---|
KR20220106285A (en) | 2022-07-29 |
KR20230096938A (en) | 2023-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10434048B2 (en) | Topical sunscreen composition, method of preparation, and use thereof | |
KR101996254B1 (en) | A anti-UV complexed powder coated with inorganic UV block agent, organic UV absorbent and anti-UV cosmetic composition using the same | |
KR101727527B1 (en) | Manufacturing method of aqueous dispersions containing titanium dioxide and zinc oxide and cosmetic composition for protecting containing thereof | |
CN116261553A (en) | Zinc oxide particles, photostable UV filters, and methods of use thereof | |
KR102074889B1 (en) | A cosmetic composition for blocking ultraviolet and blue light | |
KR101049238B1 (en) | Sunscreen powder cosmetic composition | |
EP4398993A1 (en) | Sunscreen composition and methods of protection from ultraviolet and visible light | |
KR102532227B1 (en) | Organic-inorganic hybrid material for blocking ultraviolet and blue light and preparation method thereof | |
KR102534801B1 (en) | Cosmetic composition for blocking ultraviolet lays and blue light | |
KR102633795B1 (en) | An Organic and Inorganic Convergent Type of a Hybrid Complex Composition for Shielding a Harmful Light | |
KR20130047555A (en) | Organic-inorganic composite powder for blocking uv and the cosmetic composition containing thereof | |
KR20120033593A (en) | Composite dispersion for sun screnn and manufacturing method thereof | |
KR20180079673A (en) | Skin whitening and sunscreen composition comprising nano materials and chinese medicine extract | |
KR20210036837A (en) | Sunscreen composition containing cerium oxide flake and inorganic uv-screening agent particle | |
KR20210036850A (en) | Sunscreen composition containing water dispersed cerium oxide flake | |
KR102190530B1 (en) | Cosmetic composition for blocking ultraviolet and infrared ray | |
KR20180082853A (en) | Skin whitening and sunscreen composition comprising nano materials and chinese medicine extract | |
KR20190063213A (en) | UV blocking dispersion having mixed organic and inorganinc UV blocking agents, Cosmetic composition comprising the same and its Preparation Methods | |
JP7188447B2 (en) | Electromagnetic wave absorber, sunscreen, optical component, glasses, and method for producing electromagnetic wave absorber | |
KR101238379B1 (en) | Titanium dioxide capsules containing ultraviolet absorber and the cosmetic composition containing the same | |
RU2297826C1 (en) | Photoprotective agent against uv-irradiation | |
KR20180047152A (en) | Skin whitening and sunscreen composition comprising nano materials and chinese medicine extract | |
CN115444767A (en) | Sunscreen composition and preparation method thereof | |
KR20210036787A (en) | Sunscreen composition containing cerium oxide flake and organic uv-screening agent | |
KR20190052778A (en) | A UV-shield Dispersion containing TDSA and UV-shield cosmetic composition comprising of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |